Infusion Therapy Billing: 96365 to 96368, Hydration 96360 to 96361, IV Push, and J-Code Wastage

Direct answer: Infusion therapy billing turns on two decisions made in order, and getting either one wrong produces a denial even when the infusion itself was perfectly documented. The first decision is which service is the initial code, because only one initial code is reported per encounter and the hierarchy decides it, not the clock: chemotherapy administration outranks therapeutic infusion, which outranks an IV push, which outranks hydration, regardless of the order the drugs actually ran in. The second decision is time, because every code in the 96360 to 96379 and 96401 to 96425 families is a time-based code with a threshold that must be met before it can be reported at all: hydration needs at least 31 minutes, a therapeutic infusion needs more than 15 minutes, an IV push is 15 minutes or less, and an additional hour is not reported until the infusion has run more than 30 minutes past the prior hour. Once those two decisions are right, the drug line follows its own rules: the J-code units must reconcile to the dose and the code's unit definition, and for Medicare Part B a separately payable drug from a single-dose vial needs modifier JW on a separate line for the amount discarded, or modifier JZ when nothing was discarded.
THE INITIAL CODE RULE, ONE PER ENCOUNTER
Only one initial code is reported per encounter, and every other infusion or injection service in the same encounter is reported as a subsequent or add-on code. The initial codes are 96360 for hydration, 96365 for a therapeutic, prophylactic or diagnostic infusion, 96374 for an IV push, 96409 for a chemotherapy push, and 96413 for a chemotherapy infusion. The order in which the services were delivered does not decide which one is initial. A hydration infusion that ran first in the morning does not become the initial code if a therapeutic infusion ran later the same day, because the hierarchy, not the clock, picks the initial service. The one routine exception is separate IV access sites: when infusions are given through two separate IV sites, an initial code may be reported for each site, with modifier 59 or an X modifier such as XU or XS appended and documentation that names both sites. Without two documented sites, a second initial code in the same encounter is a duplicate and will be denied. The practical habit that prevents this error is to code the encounter backwards: pick the initial code from the hierarchy first, then fit every other service around it as a sequential, concurrent or additional-hour add-on, and never let the charge description master default to an initial code for every line.
THE HIERARCHY, CHEMOTHERAPY FIRST, THEN THERAPEUTIC INFUSION, THEN HYDRATION
The CPT hierarchy for drug administration ranks the services from highest to lowest, and the highest-ranked service furnished in the encounter is reported as the initial code. Chemotherapy infusion ranks first, followed by chemotherapy injection, then therapeutic, prophylactic or diagnostic infusion, then therapeutic injection or IV push, and finally hydration. This hierarchy applies to facility coding and is the same order most payers expect in the office, although in a physician office the initial code is also described as the primary reason for the visit. The consequence that surprises coders most is hydration: hydration is always the lowest-ranked service, so when a therapeutic infusion or a chemotherapy infusion occurs in the same encounter, hydration is never the initial code. It is reported only as a subsequent service, with 96361, and only when it ran at a time that did not overlap the drug infusion, because hydration running at the same time as a drug infusion is incidental hydration and is bundled into the drug administration. Fluids used only to dilute a drug or to keep the IV line open are not hydration at all, and neither is maintenance IV therapy that replaces ordinary fluid losses rather than treating a pathological condition.
| Rank | Service family | Initial code |
|---|---|---|
| 1 | Chemotherapy infusion | 96413 |
| 2 | Chemotherapy injection or push | 96409 |
| 3 | Therapeutic, prophylactic or diagnostic infusion | 96365 |
| 4 | Therapeutic injection or IV push | 96374 |
| 5 | Hydration | 96360, reported as 96361 when a higher-ranked service is the initial code |
THE TIME TABLE, EVERY THRESHOLD THAT DECIDES A CODE
Infusion codes are time-based, and the infusion start and stop times in the record are what the code must match. A therapeutic infusion must run more than 15 minutes, which in practice means 16 minutes or more, to be reported as 96365, and it covers up to the first hour. An infusion of 15 minutes or less is not an infusion for coding purposes at all, it is an IV push reported with 96374. Hydration has a higher floor: 96360 requires at least 31 minutes of hydration, and hydration of 30 minutes or less is not reported. An additional hour is not reported on a 31-minute or 61-minute infusion: the add-on codes 96361 for hydration, 96366 for therapeutic infusion and 96415 for chemotherapy infusion are reported only once the infusion has run more than 30 minutes past the prior hour, so the first add-on unit begins at a total of 91 minutes. A sequential infusion of a new drug, 96367, covers up to one hour, and if that same sequential drug keeps running past the hour, the extra time is reported with the additional-hour code 96366 rather than with another 96367. A concurrent infusion, 96368, is reported once per encounter. The common error is to round the time up to the next code: a 70-minute infusion supports 96365 alone, because the additional hour needs a full 30 additional minutes documented beyond the first hour, and a 45-minute hydration supports 96360 only when no higher-ranked service was furnished in the same encounter.
| Code | Service | Time rule |
|---|---|---|
| 96360 | Hydration, initial | 31 minutes to 1 hour, not reported at 30 minutes or less |
| 96361 | Hydration, each additional hour | Once the infusion runs more than 30 minutes past the prior hour, first unit at 91 minutes |
| 96365 | Therapeutic, prophylactic or diagnostic infusion, initial | More than 15 minutes, in practice 16 minutes or more, up to 1 hour |
| 96366 | Therapeutic infusion, each additional hour | Once the infusion runs more than 30 minutes past the prior hour, first unit at 91 minutes |
| 96367 | Sequential infusion of a new drug | Up to 1 hour, additional time for the same drug uses 96366 |
| 96368 | Concurrent infusion | Reported once per encounter |
| 96374 | IV push, single or initial drug | 15 minutes or less |
| 96375 | Sequential IV push of a new drug | 15 minutes or less, add-on |
| 96376 | Sequential IV push of the same drug, facility only | 15 minutes or less, at least 30 minutes after the prior push |
| 96409 | Chemotherapy push, initial | 15 minutes or less |
| 96413 | Chemotherapy infusion, initial | More than 15 minutes, in practice 16 minutes or more, up to 1 hour |
| 96415 | Chemotherapy infusion, each additional hour | Once the infusion runs more than 30 minutes past the prior hour, first unit at 91 minutes |
| 96417 | Sequential chemotherapy infusion of a new drug | Up to 1 hour |
SEQUENTIAL VERSUS CONCURRENT, THE TWO WORDS THAT DECIDE 96367 AND 96368
A sequential infusion is a new drug given after the primary or initial service has finished, through the same IV access, and it is reported with 96367 for a therapeutic infusion or 96417 for a chemotherapy infusion. A concurrent infusion is a different drug running at the same time as the primary infusion, through the same IV access, and it is reported with 96368, once per encounter. The distinction is timing, not the drug: the same second drug is sequential if it starts after the first infusion ends and concurrent if it overlaps it. A sequential infusion covers up to one hour, and a concurrent infusion is reported once even if more than one drug runs at the same time. The documentation must show the start and stop times of each drug separately, because without separate times an auditor cannot tell whether the second drug was sequential or concurrent. When the second drug is given by IV push rather than by infusion, the push rules apply instead: 96375 for a new drug by sequential push, and 96376 for a repeat push of the same drug in a facility, only when at least 30 minutes have passed since the prior push.
IV PUSH, 96374, 96375 AND 96376
An IV push is an injection in which the clinician is continuously present to give the drug and watch the patient, or an infusion of 15 minutes or less, and it is reported with 96374 for the single or initial drug. Each additional sequential push of a new drug is reported with 96375. A repeat push of the same drug is reported with 96376, but only in a facility setting and only when at least 30 minutes have passed since the prior push, so a second push of the same drug 10 minutes later in an office is not a second billable push. An IV push is never reported alongside an initial therapeutic infusion for the same drug in the same encounter unless the push meets the criteria for a separate service. A vaccine given intramuscularly is a different kind of administration altogether and is not reported with 96374; vaccine administration has its own codes, explained in Vaccine Administration Billing: CPT 90471 and 90472.
CHEMOTHERAPY ADMINISTRATION, 96413 TO 96417, AND THE BIOLOGIC QUESTION
Chemotherapy administration codes apply to parenteral administration of non-radionuclide anti-neoplastic drugs, and also to anti-neoplastic agents given for noncancer diagnoses, such as cyclophosphamide for an autoimmune condition, and to certain monoclonal antibodies and other biologic response modifiers. The initial chemotherapy infusion is 96413, the initial chemotherapy push is 96409, the additional hour is 96415, and a sequential chemotherapy infusion of a new drug is 96417. Chemotherapy administration is treated as highly complex because it requires physician or qualified health professional work and monitoring well beyond the level of a therapeutic infusion, which is why it outranks every other service in the hierarchy. The contested cases are the biologics infliximab and rituximab: many payers report them with the chemotherapy administration codes 96413 and 96415, while other biologics are reported with the therapeutic infusion codes 96365 and 96366, and some Medicare contractors publish their own lists of which drugs count as chemotherapy administration. Do not present a biologic as a chemotherapy-administration code or as a therapeutic-infusion code without checking the payer or Medicare Administrative Contractor list that applies to the claim. A January 2025 CMS update to the Internet Only Manual, Publication 100-04, Chapter 12, Section 30.5, adds that Medicare may consider multiple factors when deciding whether the level of intensity for a complex drug administration service has been met, rather than just the drug name alone, so the drug name is not the whole answer.
THE DRUG LINE, J-CODES, UNITS AND WASTAGE
The administration code pays for giving the drug, and the J-code pays for the drug itself, and the two lines must reconcile. J-code units are reported in multiples of the dosage in the HCPCS code descriptor, so a drug whose code descriptor is 10 milligrams per unit and a dose of 80 milligrams is billed as 8 units, not as 80 units and not as one unit. The units on the claim must match the dose in the record and the vial or package size on the inventory record, because a mismatch between the billed units, the documented dose and the National Drug Code package size is one of the fastest routes to an audit. For Medicare Part B, a separately payable drug supplied in a single-dose vial or single-use package carries a wastage rule: when part of the vial is discarded, the discarded amount is reported on a separate claim line with the same J-code plus modifier JW and the discarded units, and the administered amount is reported on its own line without JW. When the whole vial is given and nothing is discarded, the administered line carries modifier JZ, which attests that there was no waste to report. The JZ attestation has been required since July 1, 2023, and claims for single-dose container drugs without JW or JZ can be returned as unprocessable. JW is not permitted when the actual dose given is less than one billing unit, because in that case the single billing unit already covers the whole vial, and JW is never used for a multi-use vial, since the remainder of a multi-use vial is not discarded. The record for any wastage line must show the drug name, the lot number, the total volume drawn, the volume given, the volume discarded and the reason, with a staff signature, because a JW line without that documentation is an overpayment waiting to be recouped.
| Situation | Modifier | How the claim looks |
|---|---|---|
| Part of a single-dose vial discarded, discarded amount is at least one billing unit | JW | Two lines: administered units with no modifier, discarded units with JW |
| Whole labeled amount given, nothing discarded | JZ | One line: administered units with JZ |
| Dose given is less than one billing unit | JZ | One line: the full billing unit with JZ, no JW line |
| Multi-use vial | Neither | No JW or JZ, the remainder is not discarded |
| Drug is not separately payable under Part B | Neither | JW and JZ apply only to separately payable Part B drugs |
THE 340B TB MODIFIER, AND THE RETIREMENT OF JG
A 340B covered entity that buys a drug through the 340B Drug Pricing Program must identify it on the claim, because 340B drug units are excluded from the Medicare Part B inflation rebate program. Effective January 1, 2025, CMS requires all 340B covered entities, including hospital-based and non-hospital-based entities, to report modifier TB on claim lines for separately payable Part B drugs and biologicals acquired through the 340B program, and providers and suppliers affiliated with a 340B covered entity, such as contract pharmacies, must do the same. The older JG modifier, which many covered entities used from 2018 through 2024, has not been valid for this purpose since January 1, 2025, and a claim line still carrying JG will be rejected. TB is an informational modifier: it identifies the drug as 340B-acquired so CMS can apply the inflation rebate rules correctly, and it does not change the payment on the line. The TB rule and the JW and JZ rules can both apply to the same drug line, because they answer different questions: TB says where the drug was bought, and JW or JZ says how much of the vial was used. Note that the modifier rules change again soon: CMS finalized a change effective January 1, 2027 under which modifier JG returns to identify 340B-acquired drugs subject to a payment reduction for non-exempt hospitals, while TB continues to identify exempt 340B drugs, so do not hard-code the 2025 rule as permanent.
OFFICE VERSUS FACILITY, THE SPLIT THAT DECIDES WHO REPORTS THE CODES
The drug administration codes 96360 to 96379, 96401 to 96425 and 96521 to 96523 are reportable by physicians for services performed in a physician office, but physicians do not report them for services provided in a facility setting such as a hospital outpatient department or an emergency department. That is the CMS Internet Only Manual, Publication 100-04, Chapter 12, Section 30.5. In a facility setting the facility reports the administration service and is paid for it, while the physician reports only the professional service actually furnished. Drug administration services performed in an ambulatory surgical center are also not separately reported by physicians. Hospital outpatient facilities may separately report drug administration services when appropriate. The same split applies to hydration: the hydration codes are not intended to be reported by a physician in the facility setting, because they most likely represent facility charges, but in a physician office, Place of Service 11, the physician may report them when the physician or the physician's clinical staff administers the fluids. Before a claim goes out, check the place of service first, because a perfectly coded infusion in the wrong setting is still denied.
SERVICES THAT ARE BUNDLED AND NEVER SEPARATE
Several services performed to facilitate an infusion or injection are included in the administration code and are never separately billable. The IV start, code 36000, is included in the initial infusion or push code and is not reported alongside 96360, 96365 or 96374. Preparation of the chemotherapy agent is included in the chemotherapy administration codes. Incidental hydration, meaning fluids given at the same time as a drug infusion to dilute the drug or keep the line open, is included and is not separately reported as 96360. Supplies, syringes, tubing, pumps and the local anesthesia used for the access are part of the administration service. The test is purpose: if the service exists only to make the infusion happen, it is part of the infusion, and a separate line for it is unbundling.
DOCUMENTATION THAT SURVIVES AN AUDIT
An infusion claim is audited on its times and its drug math, so the record must carry both. The infusion record should show the drug or fluid, the dose, the route, the IV access site, the start and stop time of each drug separately, the total infusion time, the clinician who gave it, and the patient response. The drug record should show the J-code, the National Drug Code, the lot number, the vial size, the units given, the units discarded and the reason for any discard, with a staff signature. The order must support medical necessity for the drug and for hydration: hydration is reportable only when IV fluids are the accepted standard of practice for the patient's condition, meet but do not exceed the patient's medical need, and cannot be met with oral hydration. When an evaluation and management service is billed on the same day as an infusion, the record must show a significant, separately identifiable service beyond the infusion itself, and the E and M code carries modifier 25. For how modifier 25 works and when it survives review, see Modifier 25 Denial Appeal.
WORKED EXAMPLE, ALL FIGURES ILLUSTRATIVE
Every figure in this example is illustrative. A patient arrives dehydrated and is scheduled for a therapeutic infusion of an antibiotic. Normal saline runs from 09:00 to 09:45, a total of 45 minutes, and the antibiotic infusion runs from 10:00 to 11:40, a total of 100 minutes, through the same IV site. A second drug, an antiemetic, is then infused sequentially from 11:45 to 12:30, a total of 45 minutes. The hierarchy decides the initial code: the therapeutic infusion outranks hydration, so the antibiotic infusion is the initial service, reported as 96365 for the first hour. The antibiotic ran 100 minutes, which is more than 30 minutes past the first hour, so one unit of the additional-hour code 96366 is also reported, because the first add-on unit begins at 91 minutes. The hydration ran 45 minutes and did not overlap the drug infusion, so it is reportable, but as a subsequent service, reported as 96361, not 96360, because the encounter already has an initial code and hydration is the lowest-ranked service. The antiemetic is a new drug given after the primary infusion ended, so it is a sequential infusion, reported as 96367 for up to one hour. The claim carries four administration lines: 96365, 96366, 96361 and 96367. The drug line is separate: the antibiotic is supplied in a 100-milligram single-dose vial, billed in 1-milligram units, the patient receives 80 milligrams and 20 milligrams are discarded, so the J-code is reported as 80 units on the administered line and 20 units on a second line with modifier JW.
COMMON MISTAKES THAT TRIGGER DENIALS
The first common mistake is reporting two initial codes in one encounter, such as 96365 and 96360 together, when only one initial code is allowed and the hierarchy picks the therapeutic infusion. The second is coding a 15-minute infusion as 96365 instead of an IV push 96374, or coding a 20-minute hydration as 96360 when hydration needs at least 31 minutes. The third is adding 96366 to a 70-minute infusion, when the additional hour needs more than 30 minutes past the first hour and the first add-on unit begins at 91 minutes. The fourth is reporting a sequential infusion as concurrent, or reporting 96368 more than once per encounter. The fifth is billing hydration alongside a drug infusion that ran at the same time, which is incidental hydration and bundled, not a separate service. The sixth is reporting the IV start 36000 alongside the initial infusion code, or reporting preparation of the chemotherapy agent as a separate line. The seventh is a J-code line whose units do not match the dose and the code descriptor, or a single-dose vial line with neither JW nor JZ for a Medicare Part B claim. The eighth is a 340B drug line still carrying modifier JG, which has not been valid since January 1, 2025, instead of TB. The ninth is reporting a biologic with a chemotherapy administration code without checking the payer or Medicare Administrative Contractor list. The tenth is a physician reporting 96360 through 96379 for a service provided in a hospital outpatient department or emergency department, where the facility reports the administration service. Each of these is preventable by checking three things before the claim goes out: which service the hierarchy makes initial, how long each infusion actually ran, and whether the drug line reconciles to the dose, the vial and the wastage attestation.
CHECKLIST
Pick the initial code from the hierarchy first, chemotherapy infusion, then therapeutic infusion, then IV push, then hydration, and report only one initial code per encounter unless two separate IV sites are documented with modifier 59 or an X modifier. Confirm each infusion ran long enough for its code: more than 15 minutes for 96365 and 96413, at least 31 minutes for 96360, 15 minutes or less for an IV push 96374. Add an additional-hour code only when the infusion ran more than 30 minutes past the prior hour, with the first add-on unit beginning at 91 minutes. Decide sequential versus concurrent from the start and stop times: a new drug after the primary infusion ends is 96367 or 96417, a different drug running at the same time is 96368 once per encounter. Check the payer or Medicare Administrative Contractor list before reporting a biologic such as infliximab or rituximab with a chemotherapy administration code. Reconcile the J-code units to the dose and the code descriptor, report discarded amounts from a single-dose vial on a separate line with JW, and append JZ to the administered line when nothing was discarded. Report modifier TB on separately payable Part B drug lines for 340B-acquired drugs, and remove any JG modifier, which has not been valid since January 1, 2025. Confirm the place of service: report 96360 through 96379 in a physician office, and do not report them as a physician service in a hospital outpatient department or emergency department. Never report the IV start 36000, preparation of the chemotherapy agent, or incidental hydration as separate lines. Document the start and stop time of each drug separately, the IV site, the lot number, the volume given and the volume discarded, and keep the order and the payer policy with the record.
FREQUENTLY ASKED QUESTIONS
What is the initial code for an infusion encounter? The initial code is the highest-ranked service in the hierarchy: chemotherapy infusion first, then therapeutic infusion, then IV push, then hydration, and only one initial code is reported per encounter. Can I report two initial codes in one visit? Only when the infusions use two separate IV access sites, with modifier 59 or an X modifier and documentation naming both sites. How long must a therapeutic infusion run to bill 96365? More than 15 minutes, in practice 16 minutes or more, up to the first hour; an infusion of 15 minutes or less is an IV push, 96374. How long must hydration run to bill 96360? At least 31 minutes; hydration of 30 minutes or less is not reported. When do I add 96366? Only when the infusion runs more than 30 minutes past the prior hour, so the first additional-hour unit begins at a total of 91 minutes. What is the difference between 96367 and 96368? A sequential infusion, 96367, is a new drug given after the primary infusion has finished, while a concurrent infusion, 96368, is a different drug running at the same time as the primary infusion, and 96368 is reported once per encounter. What is the difference between 96375 and 96376? Code 96375 is a sequential IV push of a new drug, and 96376 is a sequential IV push of the same drug, reported only in a facility and only at least 30 minutes after the prior push. Can a physician bill 96365 for a hospital outpatient infusion? No. Physicians report 96360 through 96379 for services in a physician office, and do not report them for services provided in a facility setting such as a hospital outpatient department or emergency department, under the CMS Internet Only Manual, Publication 100-04, Chapter 12, Section 30.5. How do I code infliximab or rituximab? Check the payer or Medicare Administrative Contractor list first: many payers report them with the chemotherapy administration codes 96413 and 96415, while other biologics are reported with 96365 and 96366, and the same drug can be coded differently by different payers.
A note on codes and coverage: This article is educational information about medical billing rules, not legal, financial or compliance advice. Codes, coverage rules and payer policies vary and change over time, so always verify the current rule against the CMS manuals and the specific payer policy before acting. The worked example uses illustrative figures only. The time thresholds were verified at writing time against the CPT descriptors as reflected in current coding guidance, the office-versus-facility rule against the CMS Internet Only Manual, Publication 100-04, Chapter 12, Section 30.5, and the 340B TB modifier rule against CMS guidance MLN4800856, effective January 1, 2025.
Having trouble with infusion therapy billing, or with hydration, IV push and J-code denials? Neximed Billing provides denial management, corrected claim review and billing workflow support. Contact us at info@neximedbilling.com or +1-406-2251570.
Related reading: Vaccine Administration Billing: CPT 90471 and 90472 · Modifier 25 Denial Appeal · Claim Denial Codes: Complete Guide